The Company Alzamend Neuro Inc (United States), is listed on Nasdaq with a market value of $ 3.80 Millions, having an equity of $ 2.18 Millions.
The Company is listedthe in the sector of Others and categorized in industry of Others.
In the last 12 months the Company had a revenue of $ -, which generated a loss in the amount of $ -7.04 Millions.
As for its main indicators, the Company has a P/E ratio of -0.54, a P/BV ratio of 1.74 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker ALZN.